QA: Inmed Pharmaceuticals Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001728328_2022_Inmed_Pharmaceuticals_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001728328, Inmed Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 8,378,269
1 IntangibleAssetsNetIncludingGoodwill 1,061,697
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 341,250
4 LiabilitiesCurrent 2,215,361
5 LiabilitiesNoncurrent 189,288
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,479,333
9 ResearchAndDevelopmentExpense 5,338,084
10 remainder_Expenses 120,866
11 remainder_Revenues 0
12 remainder_NetIncome -264,806
13 remainder_ComprehensiveNetIncome 430,443
  yvar yval
0 Assets 9,781,216
1 Liabilities 2,404,649
2 Expenses 9,938,283
3 Revenues 0
4 StockholdersEquity 7,376,567
5 NetIncome -10,203,089
6 ComprehensiveNetIncome -9,987,868
7 BaseVar 11,409,698
8 EconomicCapitalRatiobeforeLimitedLiability 1.00
9 EconomicCapitalRatio 2.30

Edgar->Model Mapping

Feature Distribution

Change over Time